SRC and cancer: As we previously reported, increased CAV1 expression observed in response to the treatment of cancer cells with cytotoxic drugs increases ROS production and the metastatic potential in a manner that is precluded by Src-family kinase inhibitors, underscoring the relevance of tyrosine phosphorylation in this context [39].